Matthew Nayor1,2, Martin G Larson1,3, Na Wang4, Rajalakshmi Santhanakrishnan5, Douglas S Lee6,7, Connie W Tsao1,8, Susan Cheng1,2, Emelia J Benjamin1,9, Ramachandran S Vasan1,9, Daniel Levy1,10, Caroline S Fox1,10,11, Jennifer E Ho1,12. 1. National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA. 2. Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA. 3. Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA. 4. Data Coordinating Center, Boston University School of Public Health, Boston, MA, USA. 5. Section of Cardiovascular Medicine, Department of Medicine, Boston University, Boston, MA, USA. 6. Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, Canada. 7. Peter Munk Cardiac Centre, University Health Network, Toronto, Canada. 8. Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, MA, USA. 9. Sections of Preventive Medicine & Epidemiology, and Cardiology, Department of Medicine, Boston University School of Medicine, and Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA. 10. Center for Population Studies of the National Heart, Lung, and Blood Institute, Bethesda, MD, USA. 11. Division of Endocrinology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. 12. Cardiology Division and Cardiovascular Research Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Abstract
AIMS: Chronic kidney disease (CKD) and microalbuminuria are associated with incident heart failure (HF), but their relative contributions to HF with preserved vs. reduced EF (HFpEF and HFrEF) are unknown. We sought to evaluate the associations of CKD and microalbuminuria with incident HF subtypes in the community-based Framingham Heart Study (FHS). METHODS AND RESULTS: We defined CKD as glomerular filtration rate <60 mL/min/1.73 m2 , and microalbuminuria as a urine albumin to creatinine ratio (UACR) ≥17 mg/g in men and ≥25 mg/g in women. We observed 754 HF events (324 HFpEF/326 HFrEF/104 unclassified) among 9889 FHS participants with serum creatinine measured (follow-up 13 ± 4 years). In Cox models adjusted for clinical risk factors, CKD (prevalence = 9%) was associated with overall HF [hazard ratio (HR) 1.24, 95% confidence interval (CI) 1.01-1.51], but was not significantly associated with individual HF subtypes. Among 2912 individuals with available UACR (follow-up 15 ± 4 years), 192 HF events (91 HFpEF/93 HFrEF/8 unclassified) occurred. Microalbuminuria (prevalence = 17%) was associated with a higher risk of overall HF (HR 1.71, 95% CI 1.25-2.34) and HFrEF (HR 2.10, 95% CI 1.35-3.26), but not HFpEF (HR 1.26, 95% CI 0.78-2.03). In cross-sectional analyses, microalbuminuria was associated with LV systolic dysfunction (odds ratio 3.19, 95% CI 1.67-6.09). CONCLUSIONS: Microalbuminuria was associated with incident HFrEF prospectively, and with LV systolic dysfunction cross-sectionally in a community-based sample. In contrast, CKD was modestly associated with overall HF but not differentially associated with HFpEF vs. HFrEF. The mechanisms responsible for the relationship of microalbuminuria to future development of HFrEF warrant further investigation.
AIMS: Chronic kidney disease (CKD) and microalbuminuria are associated with incident heart failure (HF), but their relative contributions to HF with preserved vs. reduced EF (HFpEF and HFrEF) are unknown. We sought to evaluate the associations of CKD and microalbuminuria with incident HF subtypes in the community-based Framingham Heart Study (FHS). METHODS AND RESULTS: We defined CKD as glomerular filtration rate <60 mL/min/1.73 m2 , and microalbuminuria as a urine albumin to creatinine ratio (UACR) ≥17 mg/g in men and ≥25 mg/g in women. We observed 754 HF events (324 HFpEF/326 HFrEF/104 unclassified) among 9889 FHS participants with serum creatinine measured (follow-up 13 ± 4 years). In Cox models adjusted for clinical risk factors, CKD (prevalence = 9%) was associated with overall HF [hazard ratio (HR) 1.24, 95% confidence interval (CI) 1.01-1.51], but was not significantly associated with individual HF subtypes. Among 2912 individuals with available UACR (follow-up 15 ± 4 years), 192 HF events (91 HFpEF/93 HFrEF/8 unclassified) occurred. Microalbuminuria (prevalence = 17%) was associated with a higher risk of overall HF (HR 1.71, 95% CI 1.25-2.34) and HFrEF (HR 2.10, 95% CI 1.35-3.26), but not HFpEF (HR 1.26, 95% CI 0.78-2.03). In cross-sectional analyses, microalbuminuria was associated with LV systolic dysfunction (odds ratio 3.19, 95% CI 1.67-6.09). CONCLUSIONS: Microalbuminuria was associated with incident HFrEF prospectively, and with LV systolic dysfunction cross-sectionally in a community-based sample. In contrast, CKD was modestly associated with overall HF but not differentially associated with HFpEF vs. HFrEF. The mechanisms responsible for the relationship of microalbuminuria to future development of HFrEF warrant further investigation.
Authors: Linda F Fried; Michael G Shlipak; Casey Crump; Anthony J Bleyer; John S Gottdiener; Richard A Kronmal; Lewis H Kuller; Anne B Newman Journal: J Am Coll Cardiol Date: 2003-04-16 Impact factor: 24.094
Authors: R B Devereux; M J Roman; J E Liu; T K Welty; E T Lee; R Rodeheffer; R R Fabsitz; B V Howard Journal: Am J Cardiol Date: 2000-11-15 Impact factor: 2.778
Authors: Erin D Unger; Ruth F Dubin; Rajat Deo; Vistasp Daruwalla; Julie L Friedman; Crystal Medina; Lauren Beussink; Benjamin H Freed; Sanjiv J Shah Journal: Eur J Heart Fail Date: 2015-12-03 Impact factor: 15.534
Authors: Kevin Damman; Mattia A E Valente; Adriaan A Voors; Christopher M O'Connor; Dirk J van Veldhuisen; Hans L Hillege Journal: Eur Heart J Date: 2013-10-27 Impact factor: 29.983
Authors: Aaron M Hein; Julia J Scialla; Daniel Edmonston; Lauren B Cooper; Adam D DeVore; Robert J Mentz Journal: JACC Heart Fail Date: 2019-05 Impact factor: 12.035
Authors: Ann A Wang; Xuan Cai; Anand Srivastava; Pottumarthi V Prasad; Stuart M Sprague; James Carr; Myles Wolf; Joachim H Ix; Geoffrey A Block; Michel Chonchol; Kalani L Raphael; Alfred K Cheung; Dominic S Raj; Jennifer J Gassman; Amir Ali Rahsepar; John P Middleton; Linda F Fried; Roberto Sarnari; Tamara Isakova; Rupal Mehta Journal: Kidney360 Date: 2021-11-18
Authors: Luke N Bailey; Emily B Levitan; Suzanne E Judd; Madeline R Sterling; Parag Goyal; Mary Cushman; Monika M Safford; Orlando M Gutiérrez Journal: JACC Heart Fail Date: 2019-05 Impact factor: 12.035
Authors: Milton Packer; Carolyn S P Lam; Lars H Lund; Mathew S Maurer; Barry A Borlaug Journal: Eur J Heart Fail Date: 2020-06-26 Impact factor: 15.534
Authors: Ömer Doğan Alataş; Murat Biteker; Ahmet Demir; Birdal Yıldırım; Ethem Acar; Kemal Gökçek; Aysel Gökçek Journal: Arq Bras Cardiol Date: 2022-04 Impact factor: 2.000